Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Covington
Citi
Daiichi Sankyo
Fish and Richardson
Colorcon
Teva
Baxter

Generated: July 23, 2018

DrugPatentWatch Database Preview

Nelarabine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for nelarabine and what is the scope of nelarabine patent protection?

Nelarabine
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nelarabine. Two suppliers are listed for this compound.
Summary for nelarabine
Pharmacology for nelarabine
Synonyms for nelarabine
(2R,3R,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol
(2R,3R,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(2-amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(2-Amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
(2R,3S,4S,5R)-2-(2-amino-6-methoxy-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(2-azanyl-6-methoxy-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(hydroxymethyl)-5-(2-imino-6-methoxy-3,9-dihydro-2H-purin-9-yl)oxolane-3,4-diol
(3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
032N299
121032-29-9
2-(2-Amino-6-methoxy-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-Amino-6-methoxy-9-(beta-D-arabinofuranosyl)-9H-purine
2-Amino-6-methoxy-9-b-D-arabinofuranosyl-9 H-purine
2-Amino-6-methoxy-9-b-D-arabinofuranosyl-9H-purine
2-Amino-6-methoxy-9-beta-D-arabinofuranosyl-9H-purine
2-Amino-6-methoxypurine arabinoside
2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
506U
506U78
6-O-Methyl Guanosine
60158CV180
7803-88-5
9-?-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine
9-(beta-D-arabinofuranosyl)-6-methoxy-9H-purin-2-amine
9-beta -D-arabinofuranosyl-2-amino-6-methoxy-9H-purine
9-beta-D-arabinofuranosyl-2-amino-6-methoxy-9 H-purine
9-beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine
9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine
9H-Purin-2-amine, 9beta-D-arabinofuranosyl-6-methyl-
A804639
AB01274773_02
AB01274773-01
ABP000601
AC1MHTJS
AJ-45735
AK-25325
AKOS015852325
AKOS015920191
Arranon
Arranon (GlaxoSmithKline)
Arranon (TN)
Arranon, Nelarabine
Arranon/
Arranon|||Nelzarabine|||GW-506U78|||(2R,3S,4S,5R)-2-(2-Amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
ArranonG
Atriance
Atriance (TN)
AX8031634
BCP9000318
BCPP000392
BR-25325
C-58277
CAS-121032-29-9
CHEBI:63612
CHEMBL1201112
CN0033
CS-1607
D05134
D0B8UJ
DB01280
DSSTox_CID_26842
DSSTox_GSID_46842
DSSTox_RID_81952
DTXSID6046842
FT-0650169
FT-0671804
GTPL7090
GW 506U78
GW-506U
GW-506U78
GW506U78
HY-13701
IXOXBSCIXZEQEQ-UHTZMRCNSA-N
J10096
KB-274813
KB-58122
MAY
MFCD00871078
MLS003915614
MLS004774135
MLS006010906
MolPort-006-167-760
NCGC00181098-01
NCGC00274059-01
Nelarabine (Arranon)
Nelarabine (INN)
Nelarabine (JAN/USAN)
Nelarabine (JAN/USAN/INN)
Nelarabine [USAN:INN:BAN]
Nelarabine [USAN]
Nelzarabine
Nelzarabine (USAN)
Nelzarabine [USAN]
NSC 686673
NSC-686673
NSC-755985
NSC755985
NU000358
NU001611
NU001612
S-7406
S1213
SC-28312
SCHEMBL18820
SMR002544682
SR-01000931847
SR-01000931847-3
ST2419746
Tox21_112714
Tox21_112714_1
U78
UNII-60158CV180
ZINC3823492

US Patents and Regulatory Information for nelarabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp ARRANON nelarabine INJECTABLE;IV (INFUSION) 021877-001 Oct 28, 2005 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for nelarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp ARRANON nelarabine INJECTABLE;IV (INFUSION) 021877-001 Oct 28, 2005 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp ARRANON nelarabine INJECTABLE;IV (INFUSION) 021877-001 Oct 28, 2005 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp ARRANON nelarabine INJECTABLE;IV (INFUSION) 021877-001 Oct 28, 2005 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp ARRANON nelarabine INJECTABLE;IV (INFUSION) 021877-001 Oct 28, 2005 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Daiichi Sankyo
McKinsey
US Army
Accenture
Healthtrust
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.